Browsing Tag
Morningside
2 posts
AdvanCell strengthens cancer drug pipeline with $112m Series C funding
AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapy, has successfully completed an oversubscribed $112 million Series…
XtalPi raises $319m for AI based drug research and development
XtalPi, a pharma company that leverages artificial intelligence (AI) for drug discovery and development, has raised $318.8 million…